Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Agrawal, M. Castoldi, S. Altamura, M. Meister, T. Muley, C. Greene, M. Muckenthaler, M. Mall (Heidelberg, Germany; Dublin, Ireland). Implication of microRNA-148b in chronic obstructive lung disease of betaENaC-overexpressing mice. Eur Respir J 2013; 42: Suppl. 57, 1506

Member's Comments

No comment yet.

Related content which might interest you: Case control study of chronic obstructive pulmonary disease and its progression Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 Local and systemic inflammation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Biomarkers in the management of COPD Source: Eur Respir Rev 2009; 18: 96-104 Year: 2009 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Survivin in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Dysregulation of serum miRNA in chronic obstructive pulmonary disease Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD Year: 2015 Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 Pathology of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=159 Year: 2006 Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Hedgehog-interacting protein is a COPD susceptibility gene: the Rotterdam Study Source: Eur Respir J 2010; 36: 89-95 Year: 2010 Accelerated ageing and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2003 - Cigarette smoke: how it does its dirty work Year: 2003 Systemic inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Possible mechanisms underlying the development of cachexia in COPD Source: Eur Respir J 2008; 31: 492-501 Year: 2008 Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Systemic vascular function in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Multiple inflammatory hits and the pathogenesis of severe airway disease Source: Eur Respir J 2006; 27: 884-888 Year: 2006 Common airway variants and chronic obstructive pulmonary disease Source: International Congress 2015 – New observations in respiratory epidemiology Year: 2015 Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD: points to ponder Year: 2014